Big Pharma President Caught With Fake Vaccine Passport Among Other High Profile Individuals

165331332 m

By Mayukh Saha / Truth Theory

The National Police of Spain broke down a crime group that sold fake Covid-19 passports in the EU, most of which were listed in the National Vaccination Registry.

The executive of PharmaMar, Jose Maria Fernandez Sousa-Faro, is one of the major names among the 2,200 names of the network that was dismantled by the National Police.


A Covid-19 passport, Green Pass, or immunity passport, is widely required in order to enjoy many of the travel and social benefits that were freely accessible before the pandemic, such as entry to restaurants and entertainment venues.

Jose Maria Fernandez Sousa-Faro is the President of one of the largest Spanish Pharma companies and has appeared in the investigation of fake Covid-19 vaccine cards, carried out by the National Police, as reported.

Looking Into The Jenner Operation

Named the Jenner Operation, it investigates around 2,200 individuals, who had included themselves in the National Immunization Registry in exchange for money. 

Authorities say that the group charged €50 (US$56) for a negative PCR test certificate and between €200 to €1,000 ($224 to $1,124) for a Covid-19 passport.

Fernandez Sousa’s name appeared in the plot sent to courts 3 and 19 in Madrid.

Sources had explained that the businessman was included in the list made by the plot, to show that he took the “third dose”.

Police investigated the matter and found that the plot was quite active and had registered the 2,200 falsely vaccinated individuals from September 2021 to January 2022.

Jose Maria Fernandez Sousa-Faro has not testified to the Police, as of yet, while singer Omar Montes and others involved had to do so.

The 76-year-old businessman will be called by the courts to investigate this matter, just like the rest, who were included in those lists, as per the sources. PharmaMar had declined to make a comment about this incident.

Jose Maria Fernandez Sousa-Faro was a professor of Biochemistry and founded PharmaMar, back in 1986. He had been in this industry for almost 35 years and was a board member of Antibióticos, Penibérica, Pescanova, and Cooper-Zeltia, among other companies. 

PharmaMar In A Massive Dilemma

PharmaMar is one of the major pharma companies in Spain and emerged from the dissolution of Zeltia back in 2015. It brought in a revenue of 92.82 million in 2021 and earned 22 million euros in the first quarter of 2022.


Listed on the Ibex-35, PharmaMar is dedicated to researching drugs that are obtained from marine resources to combat cancer and Alzheimer’s.

The company defines itself as a company focused on cancer and is committed to R&D, inspired by the sea for the discovery of anti-tumor molecules.

PharmaMar sells Aplidin for individuals with multiple myeloma. The drug is currently in the trial phase and is pending authorization from the Ministry of Health, to treat COVID patients.

It was back in March, when PharmaMar’s President assured everyone that he had suffered from coronavirus and that he had been treated with his company’s medicines, with good results.

Image credit: 123RF

Leave Comment: